UTHealth Houston Research

October 22, 2024

At-home brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London

Written By: Deborah Mann Lake | Updated: October 22, 2024

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London.

October 10, 2024

Innovative stem cell trial for bipolar disorder at UTHealth Houston gives patient hope

Written By: Deborah Mann Lake | Updated: October 10, 2024

Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life. “For me, it was a godsend,” she said.

October 9, 2024

UTHealth Houston awarded $2.5 million grant to improve outcomes for stroke patients with large blood vessel blockages

Written By: Deborah Mann Lake | Updated: October 9, 2024

Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.

October 7, 2024

First infusion in Houston for new Alzheimer’s drug administered at UTHealth Houston

Written By: Jeannette Sanchez | Updated: October 7, 2024

UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease. The recipient, 79-year-old Terrie Frankel, received the infusion last week.

September 26, 2024

At the Bedside: Houston attorney shares her story of living with sickle cell anemia

Written By: Office of Public Affairs | Updated: September 26, 2024

From the outside, there is nothing about successful, busy attorney Brenda Adimora that hints at a disease she has fought all of her life. She maintains an active practice as a labor and employment attorney and was chair of the board of trustees of the Houston Young Lawyers Foundation.

September 26, 2024

At The Bedside: For Jesus Mata, living with idiopathic pulmonary fibrosis is not the end, but the beginning

Written By: Sydney Lowther | Updated: September 26, 2024

Since he could remember, Jesus Mata has always had a cough he could not seem to kick. He had no idea that his simple cough was a sign of a serious and life-altering illness.

September 25, 2024

UTHealth Houston’s minimally invasive treatment extends hope to patients with medication-resistant epilepsy

Written By: Laura Frnka-Davis | Updated: September 25, 2024

Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.

September 19, 2024

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

Written By: Deborah Mann Lake | Updated: September 19, 2024

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).

September 19, 2024

First patient in Texas, Southeast US, enrolled at UTHealth Houston for study of neural cell therapy product to treat epilepsy

Written By: Deborah Mann Lake | Updated: September 19, 2024

UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.

September 19, 2024

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Written By: Office of Public Affairs | Updated: September 19, 2024

UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.

Find a Doctor/Provider

Select an area

Patient Care

Patient Resources

New Patient?

Billing

Patient Services

1-855-877-2808

Customer Service Hours

Mon – Thu, 8 a.m. to 8 p.m.

Fri, 8 a.m. to 5 p.m.

Sat, 9 a.m. to 1 p.m.

CST time zone

Insurance

COVID-19

More

Alert!

News & Articles